These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 17174089

  • 1. Synthesis and activity of Combretastatin A-4 analogues: 1,2,3-thiadiazoles as potent antitumor agents.
    Wu M, Sun Q, Yang C, Chen D, Ding J, Chen Y, Lin L, Xie Y.
    Bioorg Med Chem Lett; 2007 Feb 15; 17(4):869-73. PubMed ID: 17174089
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and biological evaluation of vinylogous combretastatin A-4 derivatives.
    Kaffy J, Pontikis R, Florent JC, Monneret C.
    Org Biomol Chem; 2005 Jul 21; 3(14):2657-60. PubMed ID: 15999202
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and antitumor activity of benzils related to combretastatin A-4.
    Mousset C, Giraud A, Provot O, Hamze A, Bignon J, Liu JM, Thoret S, Dubois J, Brion JD, Alami M.
    Bioorg Med Chem Lett; 2008 Jun 01; 18(11):3266-71. PubMed ID: 18477509
    [Abstract] [Full Text] [Related]

  • 4. Novel combretastatin analogues effective against murine solid tumors: design and structure-activity relationships.
    Ohsumi K, Nakagawa R, Fukuda Y, Hatanaka T, Morinaga Y, Nihei Y, Ohishi K, Suga Y, Akiyama Y, Tsuji T.
    J Med Chem; 1998 Jul 30; 41(16):3022-32. PubMed ID: 9685242
    [Abstract] [Full Text] [Related]

  • 5. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.
    Chang JY, Yang MF, Chang CY, Chen CM, Kuo CC, Liou JP.
    J Med Chem; 2006 Oct 19; 49(21):6412-5. PubMed ID: 17034147
    [Abstract] [Full Text] [Related]

  • 6. Abilities of 3,4-diarylfuran-2-one analogs of combretastatin A-4 to inhibit both proliferation of tumor cell lines and growth of relevant tumors in nude mice.
    Sun L, Vasilevich NI, Fuselier JA, Coy DH.
    Anticancer Res; 2004 Oct 19; 24(1):179-86. PubMed ID: 15015595
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and anti-proliferative in-vitro activity of two natural dihydrostilbenes and their analogues.
    Zhang WG, Zhao R, Ren J, Ren LX, Lin JG, Liu DL, Wu YL, Yao XS.
    Arch Pharm (Weinheim); 2007 May 19; 340(5):244-50. PubMed ID: 17516577
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and cytotoxic evaluation of N-(4-methoxy-1H-benzo[d]imidazol-7-yl)-arylsulfonamide and N-aryl-(4-methoxy-1H-benzo[d]imidazol)-7-sulfonamide analogs of combretastatin A-4.
    Zhou J, Zhang Y, Cui YW, Li ZM, Song HR, Dong JH, Chen XG, Xu BL.
    J Asian Nat Prod Res; 2011 Apr 19; 13(4):330-40. PubMed ID: 21462036
    [Abstract] [Full Text] [Related]

  • 9. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.
    Carr M, Greene LM, Knox AJ, Lloyd DG, Zisterer DM, Meegan MJ.
    Eur J Med Chem; 2010 Dec 19; 45(12):5752-66. PubMed ID: 20933304
    [Abstract] [Full Text] [Related]

  • 10. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
    Pettit GR, Rhodes MR, Herald DL, Hamel E, Schmidt JM, Pettit RK.
    J Med Chem; 2005 Jun 16; 48(12):4087-99. PubMed ID: 15943482
    [Abstract] [Full Text] [Related]

  • 11. Oxazole-bridged combretastatin A analogues with improved anticancer properties.
    Biersack B, Effenberger K, Schobert R, Ocker M.
    ChemMedChem; 2010 Mar 01; 5(3):420-7. PubMed ID: 20112324
    [Abstract] [Full Text] [Related]

  • 12. Regioselective Suzuki coupling of dihaloheteroaromatic compounds as a rapid strategy to synthesize potent rigid combretastatin analogues.
    Theeramunkong S, Caldarelli A, Massarotti A, Aprile S, Caprioglio D, Zaninetti R, Teruggi A, Pirali T, Grosa G, Tron GC, Genazzani AA.
    J Med Chem; 2011 Jul 28; 54(14):4977-86. PubMed ID: 21696175
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and biological evaluation of 4-arylcoumarin analogues of combretastatins.
    Bailly C, Bal C, Barbier P, Combes S, Finet JP, Hildebrand MP, Peyrot V, Wattez N.
    J Med Chem; 2003 Dec 04; 46(25):5437-44. PubMed ID: 14640552
    [Abstract] [Full Text] [Related]

  • 14. Lead identification of conformationally restricted benzoxepin type combretastatin analogs: synthesis, antiproliferative activity, and tubulin effects.
    Barrett I, Carr M, O'Boyle N, Greene LM, Knox AJ, Lloyd DG, Zisterer DM, Meegan MJ.
    J Enzyme Inhib Med Chem; 2010 Apr 04; 25(2):180-94. PubMed ID: 20222762
    [Abstract] [Full Text] [Related]

  • 15. 23-oxa-analogues of OSW-1: efficient synthesis and extremely potent antitumor activity.
    Shi B, Wu H, Yu B, Wu J.
    Angew Chem Int Ed Engl; 2004 Aug 20; 43(33):4324-7. PubMed ID: 15368382
    [No Abstract] [Full Text] [Related]

  • 16. Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety.
    Maya AB, Pérez-Melero C, Mateo C, Alonso D, Fernández JL, Gajate C, Mollinedo F, Peláez R, Caballero E, Medarde M.
    J Med Chem; 2005 Jan 27; 48(2):556-68. PubMed ID: 15658869
    [Abstract] [Full Text] [Related]

  • 17. Antineoplastic agents. 509: synthesis of fluorcombstatin phosphate and related 3-halostilbenes(1).
    Pettit GR, Minardi MD, Rosenberg HJ, Hamel E, Bibby MC, Martin SW, Jung MK, Pettit RK, Cuthbertson TJ, Chapuis JC.
    J Nat Prod; 2005 Oct 27; 68(10):1450-8. PubMed ID: 16252907
    [Abstract] [Full Text] [Related]

  • 18. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
    Odlo K, Hentzen J, dit Chabert JF, Ducki S, Gani OA, Sylte I, Skrede M, Flørenes VA, Hansen TV.
    Bioorg Med Chem; 2008 May 01; 16(9):4829-38. PubMed ID: 18396050
    [Abstract] [Full Text] [Related]

  • 19. Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4.
    Hall JJ, Sriram M, Strecker TE, Tidmore JK, Jelinek CJ, Kumar GD, Hadimani MB, Pettit GR, Chaplin DJ, Trawick ML, Pinney KG.
    Bioorg Med Chem Lett; 2008 Sep 15; 18(18):5146-9. PubMed ID: 18710804
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and evaluation of 4/5-hydroxy-2,3-diaryl(substituted)-cyclopent-2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anticancer agents.
    Gurjar MK, Wakharkar RD, Singh AT, Jaggi M, Borate HB, Shinde PD, Verma R, Rajendran P, Dutt S, Singh G, Sanna VK, Singh MK, Srivastava SK, Mahajan VA, Jadhav VH, Dutta K, Krishnan K, Chaudhary A, Agarwal SK, Mukherjee R, Burman AC.
    J Med Chem; 2007 Apr 19; 50(8):1744-53. PubMed ID: 17373779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.